GYRE logo

Gyre Therapeutics (GYRE) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Mar 1, 2022

Total Assets

$125.2 M(+3.6%)$120.9 M(-0.9%)$122.0 M(+4.7%)$116.5 M--$110.2 M-

Current Assets

$54.8 M(+2.4%)$53.5 M(-14.7%)$62.7 M(+9.6%)$57.2 M--$47.0 M-

Non Current Assets

$70.4 M(+4.5%)$67.4 M(+13.7%)$59.3 M(-0.1%)$59.3 M--$63.2 M-

Total Liabilities

$26.8 M(-3.0%)$27.6 M(-17.0%)$33.2 M(-67.6%)$102.6 M--$13.9 M-

Current Liabilities

$14.7 M(-5.5%)$15.6 M(-20.1%)$19.5 M(-2.8%)$20.0 M--$12.8 M-

Long Term Liabilities

$12.1 M(+0.3%)$12.0 M(-12.7%)$13.8 M(-83.3%)$82.5 M--$1.1 M-

Shareholders Equity

$63.2 M(+4.7%)$60.4 M(+6.5%)$56.6 M(+457.9%)-$15.8 M--$96.3 M-

Book Value

$63.2 M(+4.7%)$60.4 M(+6.5%)$56.6 M(+457.9%)-$15.8 M--$96.3 M-

Working Capital

$40.1 M(+5.7%)$37.9 M(-12.2%)$43.2 M(+16.3%)$37.2 M--$34.2 M-

Cash And Cash Equivalents

$15.9 M(-1.4%)$16.1 M(-46.0%)$29.8 M(-11.1%)$33.5 M--$26.4 M-

Accounts Payable

$303.0 K(+11.8%)$271.0 K(-17.9%)$330.0 K(-7.0%)$355.0 K--$279.1 K-

Accounts Receivable

$19.5 M(+5.8%)$18.5 M(+21.4%)$15.2 M(+0.0%)$15.2 M--$12.5 M-

Short Term Debt

$694.0 K(+5.3%)$659.0 K(+559.0%)$100.0 K(-52.4%)$210.0 K--$506.5 K-

Long Term Debt

$1.1 M(-15.1%)$1.3 M(+641.1%)$175.0 K(-12.1%)$199.0 K--$122.4 K-

Total Debt

$1.8 M(-8.2%)$2.0 M(+611.3%)$275.0 K(-32.8%)$409.0 K(+100.0%)$0.0(0%)$0.0(-100.0%)$628.9 K(+100.0%)$0.0

Debt To Equity

0.0(0%)0.0(0%)0.0(0%)0.0--0.0-

Current Ratio

3.7(+8.1%)3.4(+6.8%)3.2(+13.0%)2.9--3.7-

Quick Ratio

3.3(+7.2%)3.1(+3.4%)3.0(+12.5%)2.6--3.2-

Inventory

$6.4 M(+13.2%)$5.6 M(+14.1%)$4.9 M(+15.4%)$4.3 M--$5.7 M-

Retained Earnings

-$73.4 M(+1.5%)-$74.5 M(+4.5%)-$78.0 M(+8.8%)-$85.5 M--$46.5 M-

PB Ratio

16.9(-0.1%)16.9(-35.9%)26.4(+121.2%)-124.3----

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Mar 1, 2022

EPS

$0.0(0%)$0.0(-66.7%)$0.0(+102.3%)-$1.3(-2640.8%)$0.1(+114.5%)$0.0(-17.4%)$0.0(-63.5%)$0.1

TTM EPS

-$1.3(-3.4%)-$1.2(-1.2%)-$1.2(+0.1%)-$1.2(-1251.1%)$0.1(+97.0%)$0.1(+82.6%)$0.0(-63.5%)$0.1

Revenue

$25.5 M(+1.0%)$25.2 M(-7.2%)$27.2 M(+0.1%)$27.1 M(-15.3%)$32.0 M(+9.3%)$29.3 M(+17.6%)$24.9 M(-0.3%)$25.0 M

TTM Revenue

$105.0 M(-5.9%)$111.6 M(-3.5%)$115.7 M(+2.0%)$113.5 M(+31.5%)$86.3 M(+59.0%)$54.3 M(+117.6%)$24.9 M(-0.3%)$25.0 M

Total Expenses

$21.3 M(-3.2%)$22.0 M(+15.0%)$19.1 M(-40.9%)$32.3 M(+67.7%)$19.3 M(-20.9%)$24.4 M(+33.3%)$18.3 M(+7.3%)$17.0 M

Operating Expenses

$20.3 M(-4.2%)$21.2 M(+16.9%)$18.1 M(-41.7%)$31.1 M(+71.8%)$18.1 M(-22.3%)$23.3 M(+35.8%)$17.1 M(+8.3%)$15.8 M

Cost Of Goods Sold

$958.0 K(+24.4%)$770.0 K(-21.4%)$979.0 K(-21.7%)$1.3 M(+5.6%)$1.2 M(+9.9%)$1.1 M(-4.3%)$1.1 M(-6.2%)$1.2 M

TTM Cost Of Goods Sold

$4.0 M(-5.4%)$4.2 M(-6.8%)$4.5 M(-3.1%)$4.6 M(+36.9%)$3.4 M(+53.8%)$2.2 M(+95.7%)$1.1 M(-6.2%)$1.2 M

Gross Profit

$24.5 M(+0.3%)$24.5 M(-6.6%)$26.2 M(+1.1%)$25.9 M(-16.1%)$30.9 M(+9.2%)$28.3 M(+18.7%)$23.8 M(-0.0%)$23.8 M

TTM Gross Profit

$101.1 M(-5.9%)$107.4 M(-3.4%)$111.2 M(+2.2%)$108.8 M(+31.2%)$82.9 M(+59.3%)$52.1 M(+118.7%)$23.8 M(-0.0%)$23.8 M

Gross Margin

96.2%(-0.7%)97.0%(+0.6%)96.4%(+1.1%)95.4%(-0.9%)96.3%(-0.0%)96.3%(+0.9%)95.5%(+0.3%)95.2%

Operating Profit

$4.2 M(+29.8%)$3.3 M(-59.6%)$8.1 M(+255.5%)-$5.2 M(-140.7%)$12.8 M(+156.6%)$5.0 M(-25.4%)$6.7 M(-16.5%)$8.0 M

TTM Operating Profit

$10.4 M(-45.1%)$18.9 M(-8.3%)$20.6 M(+7.3%)$19.2 M(-21.3%)$24.4 M(+109.7%)$11.6 M(+74.6%)$6.7 M(-16.5%)$8.0 M

Operating Margin

16.6%(+28.5%)12.9%(-56.5%)29.7%(+255.4%)-19.1%(-148.0%)39.8%(+134.9%)17.0%(-36.5%)26.7%(-16.2%)31.9%

Net Income

$1.1 M(-68.1%)$3.5 M(-53.2%)$7.5 M(+107.5%)-$101.0 M(-2640.4%)$4.0 M(+114.6%)$1.9 M(-17.4%)$2.2 M(-63.5%)$6.2 M

TTM Net Income

-$88.8 M(-3.3%)-$86.0 M(+1.9%)-$87.6 M(+5.7%)-$92.9 M(-1251.2%)$8.1 M(+97.0%)$4.1 M(+82.6%)$2.2 M(-63.5%)$6.2 M

Net Margin

4.4%(-68.5%)14.0%(-49.5%)27.7%(+107.5%)-372.1%(-3098.1%)12.4%(+96.4%)6.3%(-29.8%)9.0%(-63.4%)24.6%

EBIT

$4.2 M(+29.8%)$3.3 M(-59.6%)$8.1 M(+255.5%)-$5.2 M(-140.7%)$12.8 M(+156.6%)$5.0 M(-25.4%)$6.7 M(-16.1%)$7.9 M

TTM EBIT

$10.4 M(-45.1%)$18.9 M(-8.3%)$20.6 M(+7.3%)$19.2 M(-21.3%)$24.4 M(+109.7%)$11.6 M(+74.6%)$6.7 M(-16.1%)$7.9 M

EBITDA

$4.7 M(+33.9%)$3.5 M(-58.8%)$8.5 M(+274.1%)-$4.9 M(-137.6%)$13.0 M(+145.0%)$5.3 M(-23.9%)$7.0 M(-17.6%)$8.4 M

TTM EBITDA

$11.8 M(-41.2%)$20.1 M(-8.2%)$21.9 M(+7.6%)$20.3 M(-19.4%)$25.2 M(+105.9%)$12.2 M(+76.1%)$7.0 M(-17.6%)$8.4 M

Selling, General & Administrative Expenses

$17.5 M(-1.8%)$17.8 M(+11.9%)$15.9 M(-39.9%)$26.5 M(+75.8%)$15.1 M(-23.5%)$19.7 M(+35.9%)$14.5 M(+5.4%)$13.8 M

TTM SGA

$77.8 M(+3.2%)$75.4 M(-2.4%)$77.3 M(+1.9%)$75.8 M(+53.8%)$49.3 M(+44.1%)$34.2 M(+135.9%)$14.5 M(+5.4%)$13.8 M

Depreciation And Amortization

$454.0 K(+90.8%)$238.0 K(-44.0%)$425.0 K(+38.0%)$308.0 K(+52.5%)$202.0 K(-36.5%)$318.0 K(+11.2%)$286.0 K(-41.5%)$489.2 K

TTM D&A

$1.4 M(+21.5%)$1.2 M(-6.4%)$1.3 M(+12.5%)$1.1 M(+38.2%)$806.0 K(+33.4%)$604.0 K(+111.2%)$286.0 K(-41.5%)$489.2 K

Interest Expense

-------$13.7 K

TTM Interest Expense

-------$13.7 K

Income Tax

$1.1 M(-28.3%)$1.5 M(-41.2%)$2.5 M(+264.2%)$699.0 K(-81.0%)$3.7 M(+76.5%)$2.1 M(+1.5%)$2.1 M(+15.4%)$1.8 M

TTM Income Tax

$5.8 M(-30.9%)$8.4 M(-6.5%)$9.0 M(+5.8%)$8.5 M(+8.9%)$7.8 M(+88.9%)$4.1 M(+101.5%)$2.1 M(+15.4%)$1.8 M

PE Ratio

----64.0(+8.8%)58.9(-54.0%)128.0(+5.4%)121.4

PS Ratio

10.2(+11.0%)9.2(-29.1%)12.9(-25.6%)17.3----

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 1, 2023Jun 1, 2023Mar 1, 2023Mar 1, 2022

Cash From Operations

$1.7 M(+131.4%)-$5.5 M(-290.5%)$2.9 M(-14.2%)$3.4 M(-55.7%)$7.6 M(+67.3%)$4.5 M(-56.5%)$10.4 M(+15.8%)$9.0 M

TTM CFO

$2.5 M(-70.3%)$8.3 M(-54.6%)$18.4 M(-29.1%)$25.9 M(+14.9%)$22.5 M(+50.7%)$14.9 M(+43.5%)$10.4 M(+15.8%)$9.0 M

Cash From Investing

-$2.4 M(+71.2%)-$8.3 M(-14.6%)-$7.2 M(-639.2%)$1.3 M(+124.8%)-$5.4 M(+32.9%)-$8.1 M(-5.3%)-$7.6 M(-144.9%)-$3.1 M

TTM CFI

-$16.5 M(+15.4%)-$19.6 M(-1.1%)-$19.3 M(+2.2%)-$19.8 M(+6.3%)-$21.1 M(-34.4%)-$15.7 M(-105.3%)-$7.6 M(-144.9%)-$3.1 M

Cash From Financing

$324.0 K(+107.7%)$156.0 K(-76.3%)$658.0 K(-73.7%)$2.5 M(+100.0%)$0.0(0%)$0.0(0%)$0.0(+100.0%)-$127.9 K

TTM CFF

$3.6 M(+9.8%)$3.3 M(+4.9%)$3.2 M(+26.3%)$2.5 M(+100.0%)$0.0(0%)$0.0(0%)$0.0(+100.0%)-$127.9 K

Free Cash Flow

$1.0 M(+114.8%)-$6.9 M(-361.9%)$2.7 M(+156.3%)$1.0 M(-81.5%)$5.6 M(+172.8%)$2.1 M(-76.1%)$8.6 M(+46.6%)$5.9 M

TTM FCF

-$2.2 M(-195.1%)$2.3 M(-79.3%)$11.3 M(-34.4%)$17.3 M(+6.4%)$16.3 M(+52.6%)$10.7 M(+23.9%)$8.6 M(+46.6%)$5.9 M

CAPEX

$696.0 K(-52.2%)$1.5 M(+530.3%)$231.0 K(-90.1%)$2.3 M(+17.7%)$2.0 M(-20.3%)$2.5 M(+37.1%)$1.8 M(-42.1%)$3.1 M

TTM CAPEX

$4.7 M(-21.4%)$6.0 M(-14.6%)$7.0 M(-18.4%)$8.6 M(+37.1%)$6.3 M(+46.1%)$4.3 M(+137.1%)$1.8 M(-42.1%)$3.1 M

Dividends Paid

-------$0.0

TTM Dividends Paid

-------$0.0

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

-------0.0%